8-K filings / November 20, 2026
SeaStar Medical Holding Corp: A stock exchange listing notice
SeaStar Medical Holding Corp filed a current report (Form 8-K) with the SEC on November 20, 2026. It reports a stock exchange listing notice.
Item 3.01
Stock exchange listing notice
-
Exchange
Nasdaq
From the filing
Source
“On November 20, 2026, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that based on information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder’s equity for continued listing (the “Stockholders’ Equity Requirement”).”
Read by code from this sentence of the filing. -
What it says
The company does not meet a listing rule
From the filing
Source
“On November 20, 2026, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that based on information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder’s equity for continued listing (the “Stockholders’ Equity Requirement”).”
Read by code from this sentence of the filing. -
Rule cited
Nasdaq Listing Rule 5550(b)(1)
From the filing
Source
“On November 20, 2026, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that based on information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder’s equity for continued listing (the “Stockholders’ Equity Requirement”).”
Read by code from this sentence of the filing. -
Notice date
November 20, 2026
From the filing
Source
“On November 20, 2026, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that based on information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder’s equity for continued listing (the “Stockholders’ Equity Requirement”).”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.